Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 03 save search
Tonix Pharmaceuticals Announces FDA Orphan-Drug Designation for TNX-2900 for the Treatment of Prader-Willi Syndrome
Published: 2022-03-03 (Crawled : 20:00) - biospace.com/
TNXP | $0.159 1.27% 1.26% 1.1M
|
Health Technology
|
| O: 46.52%
H: 28.57%
C: -9.18%
tnx-2900 treatment fda als drug drug designation syndros designation
Genocea to Host Fourth Quarter 2021 Corporate Update Conference Call & Webcast
Published: 2022-03-03 (Crawled : 14:00) - biospace.com/
GNCA | $0.051
|
Health Technology
|
| O: -5.2%
H: 18.28%
C: 13.98%
conference
EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Highlights Recent Corporate Developments
Published: 2022-03-03 (Crawled : 13:30) - biospace.com/
EYPT | $17.665 0.94% 0.93% 1.5M
|
Health Technology
|
| O: 2.0%
H: 14.12%
C: 10.88%
als financial results eye report results
Fusion Fuel Green Hosts Fourth Quarter 2021 Investor Update
Published: 2022-03-03 (Crawled : 14:00) - globenewswire.com
HTOO | $1.28 -2.29% -2.34% 52K
|
|
| O: -0.17%
H: 13.17%
C: 7.5%
Titan International, Inc. Caps Off Strong 2021 With Q4 EPS of $0.44 on 49% Year Over Year Growth In Sales
Published: 2022-03-03 (Crawled : 01:00) - prnewswire.com
TWI | $11.53 0.96% 4.94% 330K
|
Producer Manufacturing
|
| O: 10.0%
H: 13.1%
C: -4.5%
sales growth
Core One Labs Announces Successful Proof-of-Concept for Biosynthetic N-methyltryptamine (NMT)
Published: 2022-03-03 (Crawled : 09:00) - globenewswire.com
CLABF | $0.17 115.0% 440
|
Process Industries
|
| O: 0.35%
H: 12.89%
C: 9.3%
one success roof
CNS Pharmaceuticals Reports Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-03 (Crawled : 14:00) - biospace.com/
CNSP | $0.1934 -5.2% -5.48% 87K
|
Health Technology
|
| O: 2.38%
H: 12.64%
C: 10.37%
als financial results report results
NYMOX Announces Submission of New Drug Application (NDA) to the FDA for Fexapotide Triflutate
Published: 2022-03-03 (Crawled : 17:00) - biospace.com/
NYMX | $0.2 -19.68% -23.88% 930K
|
Health Technology
|
| O: 1.8%
H: 11.76%
C: 3.53%
new drug fda application drug submission
Quhuo Announces Receipt of Nasdaq Notice
Published: 2022-03-03 (Crawled : 14:00) - globenewswire.com
QH | $0.626 1.18% 1.17% 43K
|
Technology Services
|
| O: 1.54%
H: 10.94%
C: 9.38%
nasdaq
Gogo Announces Record Fourth Quarter and 2021 Financial Results, Provides 2022 Guidance and Updates Long-Term Targets
Published: 2022-03-03 (Crawled : 12:30) - prnewswire.com
GOGO | $8.35 -0.24% -0.24% 700K
|
Communications
|
| O: 11.94%
H: 10.6%
C: 7.8%
financial results results
Fulcrum Therapeutics® Announces REACH, a Phase 3 Clinical Trial of Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD)
Published: 2022-03-03 (Crawled : 20:00) - biospace.com/
FULC | $6.86 -2.83% -2.92% 560K
|
Health Technology
|
| O: -1.71%
H: 10.39%
C: 7.24%
therapeutics muscular dystrophy trial phase 3
Fulcrum Therapeutics® Reports Recent Business Highlights and Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-03 (Crawled : 20:00) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.0%
H: 1.15%
C: 0.38%
FULC | $6.86 -2.83% -2.92% 560K
|
Health Technology
|
| O: -1.71%
H: 10.39%
C: 7.24%
therapeutics financial results report results
Otonomo to Present at March Investor Conferences
Published: 2022-03-03 (Crawled : 14:00) - globenewswire.com
OTMO | $5.3 4.15% 1M
|
|
| O: -3.11%
H: 10.26%
C: -2.56%
conference
American Cannabis Company Partners with Bubba Kush Cannabis Brand
Published: 2022-03-03 (Crawled : 21:00) - americancannabisconsulting.com
AMMJ 4 | $0.009 9.9% 100K
|
Manufacturing
|
| O: -6.8%
H: 8.96%
C: 8.96%
america cannabis
Regulus Therapeutics Announces Timing for Fourth Quarter and Year-End 2021 Financial Results Webcast and Conference Call
Published: 2022-03-03 (Crawled : 23:00) - prnewswire.com
RGLS | $2.13 -4.05% -4.23% 220K
|
Health Technology
|
| O: -1.0%
H: 8.85%
C: 2.2%
financial results conference therapeutics results
MiNK Therapeutics Announces Patients Dosed with AgenT-797 iNKT Cell Therapy in Solid Tumor Cancers
Published: 2022-03-03 (Crawled : 15:00) - globenewswire.com
INKT | $0.898 3.02% 2.93% 40K
|
|
| O: -0.35%
H: 8.8%
C: 2.82%
therapeutics cel therapy cancer
ReTo Eco-Solutions Subsidiary Selected as a Member of the Hainan Petroleum, Natural Gas and Chemical Industry Federation
Published: 2022-03-03 (Crawled : 13:30) - prnewswire.com
RETO | $0.8801 -7.36% -7.94% 59K
|
Non-Energy Minerals
|
| O: 6.25%
H: 8.09%
C: 1.47%
natural gas solutions
NeuroOne to Present its Game-Changing Neuroscientific Technology at the Oppenheimer 32nd Annual Healthcare Conference and 34th Annual ROTH Conference
Published: 2022-03-03 (Crawled : 17:00) - biospace.com/
NMTC | $1.14 0.0% 19K
|
Real Estate and Rental and Leas...
|
| O: 1.57%
H: 7.73%
C: 2.58%
health neuroone thc technology conference one
Shineco, Inc. Announces New Website Launch
Published: 2022-03-03 (Crawled : 14:00) - globenewswire.com
SISI | $0.68 -5.56% -5.88% 200K
|
Manufacturing
|
| O: 4.23%
H: 7.5%
C: 7.5%
ces
Skye Bioscience Retains Novotech as CRO for Phase 1 Trial of Glaucoma Drug Candidate
Published: 2022-03-03 (Crawled : 17:00) - biospace.com/
SKYE | $16.16 -4.77% -5.01% 110K
|
Transportation and Warehousing
|
| O: 0.0%
H: 7.42%
C: 0.26%
glaucoma drug trial phase 1 bioscience phase 2 phase 3
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
GBR | $1.42 31.48% 11.27% 990K
|
Energy Minerals
KUKE | $2.88 2.49% 7.64% 360K
|
MPLN | $0.6502 -11.74% 4.51% 2.2M
|
Finance
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
PVL 4 | $1.47 -0.68% 4.08% 77K
|
Energy Minerals
RNR 4 | $224.74 0.85% 3.52% 310K
|
Finance
PZG | $0.4431 0.48% 2.91% 150K
|
Non-Energy Minerals
DBRG | $17.3 0.06% 1.97% 1.2M
|
Finance and Insurance
RC | $8.62 1.77% 0.81% 1M
|
Finance
SIX | $23.45 -0.55% 0.68% 650K
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.